The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Polysciences sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Polysciences is a manufacturer and distributor of fine and specialty chemical materials. The company’s products are used in manufacturing monomers, polymers, microparticles, specialty chemical, electronic chemical, life sciences, histology, microsopy, immunology and pathology products. The company also provides custom synthesis and contract manufacturing services. The company operates and distributes its products worldwide through its subsidiaries. Polysciences is headquartered in Warrington, Pennsylvania, the US. Key subsidiaries of Polysciences include Astral Diagnostics and Bangs Laboratories.
The key metrics of Polysciences related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Polysciences is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Polysciences.
For a detailed understanding of the performance of Polysciences, buy the report here.